209 related articles for article (PubMed ID: 27080094)
1. Towards patient stratification and treatment in the autoimmune disease lupus erythematosus using a systems pharmacology approach.
Ruiz-Cerdá ML; Irurzun-Arana I; González-Garcia I; Hu C; Zhou H; Vermeulen A; Trocóniz IF; Gómez-Mantilla JD
Eur J Pharm Sci; 2016 Oct; 94():46-58. PubMed ID: 27080094
[TBL] [Abstract][Full Text] [Related]
2. Systems pharmacology - Towards the modeling of network interactions.
Danhof M
Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
[TBL] [Abstract][Full Text] [Related]
3. Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approach.
Saafan H; Foerster S; Parra-Guillen ZP; Hammer E; Michaelis M; Cinatl J; Völker U; Fröhlich H; Kloft C; Ritter CA
Eur J Pharm Sci; 2016 Oct; 94():20-32. PubMed ID: 27112992
[TBL] [Abstract][Full Text] [Related]
4. Systems pharmacology to predict drug safety in drug development.
Trame MN; Biliouris K; Lesko LJ; Mettetal JT
Eur J Pharm Sci; 2016 Oct; 94():93-95. PubMed ID: 27251780
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
Murphy G; Lisnevskaia L; Isenberg D
Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
[TBL] [Abstract][Full Text] [Related]
6. Boolean network modeling in systems pharmacology.
Bloomingdale P; Nguyen VA; Niu J; Mager DE
J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):159-180. PubMed ID: 29307099
[TBL] [Abstract][Full Text] [Related]
7. A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Sheng-ma-bie-jia-tang Acting on Systemic Lupus Erythematosus by Multi-Level Data Integration.
Huang L; Lv Q; Liu F; Shi T; Wen C
Sci Rep; 2015 Nov; 5():16401. PubMed ID: 26560501
[TBL] [Abstract][Full Text] [Related]
8. Update on the role of autophagy in systemic lupus erythematosus: A novel therapeutic target.
Pan Q; Gao C; Chen Y; Feng Y; Liu WJ; Liu HF
Biomed Pharmacother; 2015 Apr; 71():190-3. PubMed ID: 25960235
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus.
Salek M; Hosseini Hooshiar S; Salek M; Poorebrahimi M; Jafarnejad S
Lupus; 2023 Jan; 32(1):7-22. PubMed ID: 36433776
[TBL] [Abstract][Full Text] [Related]
10. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
[TBL] [Abstract][Full Text] [Related]
11. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
12. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
13. Systems pharmacology in drug development and therapeutic use - A forthcoming paradigm shift.
Kloft C; Trame MN; Ritter CA
Eur J Pharm Sci; 2016 Oct; 94():1-3. PubMed ID: 27449395
[No Abstract] [Full Text] [Related]
14. Pathophysiology and pharmacology of systemic lupus erythematosus.
Schneider M
J Physiol Pharmacol; 1993 Sep; 44(3):187-97. PubMed ID: 8241523
[TBL] [Abstract][Full Text] [Related]
15. Animal models of systemic lupus erythematosus (SLE) and ex vivo assay design for drug discovery.
Seavey MM; Lu LD; Stump KL
Curr Protoc Pharmacol; 2011 Jun; Chapter 5():Unit 5.60. PubMed ID: 21935901
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
Sthoeger Z; Sharabi A; Mozes E
J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
[TBL] [Abstract][Full Text] [Related]
17. Macrophage subpopulations in systemic lupus erythematosus.
Orme J; Mohan C
Discov Med; 2012 Feb; 13(69):151-8. PubMed ID: 22369974
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology.
Xinqiang S; Yu Z; Ningning Y; Erqin D; Lei W; Hongtao D
Life Sci; 2020 Jan; 240():117063. PubMed ID: 31734262
[TBL] [Abstract][Full Text] [Related]
19. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
20. Block and tackle: CTLA4Ig takes on lupus.
Davidson A; Diamond B; Wofsy D; Daikh D
Lupus; 2005; 14(3):197-203. PubMed ID: 15807196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
